FDA Import Refusal 1FX-1617377-5/10002/1 — DAIICHI SANKYO (SCHWEIZ) AG
The FDA refused shipment 1FX-1617377-5/10002/1 from DAIICHI SANKYO (SCHWEIZ) AG (Switzerland) on May 29, 2026. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75
Refusal Details
- Date
- May 29, 2026
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 62ODB14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75